The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Single Cell Multiomics Market Research Report 2024
Synopsis
Market Analysis and Insights: Global Single Cell Multiomics Market
Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
The global Single Cell Multiomics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Single cell genomics accounting for % of the Single Cell Multiomics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Single Cell Multiomics market size is valued at US$ million in 2021, while the North America and Europe Single Cell Multiomics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Single Cell Multiomics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Single Cell Multiomics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Single Cell Multiomics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Single Cell Multiomics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Single Cell Multiomics market.
Global Single Cell Multiomics Scope and Market Size
Single Cell Multiomics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Single Cell Multiomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
by Type
Single cell genomics
Single cell proteomics
Single cell transcriptomics
Single cell metabolomics
by Technique
Single cell isolation and dispensing
Single cell analysis
Segment by Application
Oncology
Cell biology
Neurology
Immunology
Stem cell research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
10x Genomics
Becton, Dickinson and Company
Berkeley Lights
BGI Genomics
Bio Rad Laboratories
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Epicypher
Fluidigm Corporation
Illimina
Miltenyi Biotec B.V. & CO.
Mission Bio
Nanostring Technologies
Olink Holding AB (Olink Proteomics)
Parse Bioscience
Qiagen N.V.
Takara Holdings Inc. Takara Bio Group
Thermo Fisher Scientific
Market Analysis and Insights: Global Single Cell Multiomics Market
Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
The global Single Cell Multiomics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Single cell genomics accounting for % of the Single Cell Multiomics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Single Cell Multiomics market size is valued at US$ million in 2021, while the North America and Europe Single Cell Multiomics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Single Cell Multiomics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Single Cell Multiomics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Single Cell Multiomics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Single Cell Multiomics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Single Cell Multiomics market.
Global Single Cell Multiomics Scope and Market Size
Single Cell Multiomics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Single Cell Multiomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
by Type
Single cell genomics
Single cell proteomics
Single cell transcriptomics
Single cell metabolomics
by Technique
Single cell isolation and dispensing
Single cell analysis
Segment by Application
Oncology
Cell biology
Neurology
Immunology
Stem cell research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
10x Genomics
Becton, Dickinson and Company
Berkeley Lights
BGI Genomics
Bio Rad Laboratories
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Epicypher
Fluidigm Corporation
Illimina
Miltenyi Biotec B.V. & CO.
Mission Bio
Nanostring Technologies
Olink Holding AB (Olink Proteomics)
Parse Bioscience
Qiagen N.V.
Takara Holdings Inc. Takara Bio Group
Thermo Fisher Scientific
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Cell Multiomics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Single cell genomics
1.2.3 Single cell proteomics
1.2.4 Single cell transcriptomics
1.2.5 Single cell metabolomics
1.3 Market by Application
1.3.1 Global Single Cell Multiomics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cell biology
1.3.4 Neurology
1.3.5 Immunology
1.3.6 Stem cell research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Single Cell Multiomics Market Perspective (2017-2028)
2.2 Single Cell Multiomics Growth Trends by Region
2.2.1 Single Cell Multiomics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Single Cell Multiomics Historic Market Size by Region (2017-2022)
2.2.3 Single Cell Multiomics Forecasted Market Size by Region (2023-2028)
2.3 Single Cell Multiomics Market Dynamics
2.3.1 Single Cell Multiomics Industry Trends
2.3.2 Single Cell Multiomics Market Drivers
2.3.3 Single Cell Multiomics Market Challenges
2.3.4 Single Cell Multiomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Cell Multiomics Players by Revenue
3.1.1 Global Top Single Cell Multiomics Players by Revenue (2017-2022)
3.1.2 Global Single Cell Multiomics Revenue Market Share by Players (2017-2022)
3.2 Global Single Cell Multiomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single Cell Multiomics Revenue
3.4 Global Single Cell Multiomics Market Concentration Ratio
3.4.1 Global Single Cell Multiomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Cell Multiomics Revenue in 2021
3.5 Single Cell Multiomics Key Players Head office and Area Served
3.6 Key Players Single Cell Multiomics Product Solution and Service
3.7 Date of Enter into Single Cell Multiomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Cell Multiomics Breakdown Data by Type
4.1 Global Single Cell Multiomics Historic Market Size by Type (2017-2022)
4.2 Global Single Cell Multiomics Forecasted Market Size by Type (2023-2028)
5 Single Cell Multiomics Breakdown Data by Application
5.1 Global Single Cell Multiomics Historic Market Size by Application (2017-2022)
5.2 Global Single Cell Multiomics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Single Cell Multiomics Market Size (2017-2028)
6.2 North America Single Cell Multiomics Market Size by Country (2017-2022)
6.3 North America Single Cell Multiomics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Single Cell Multiomics Market Size (2017-2028)
7.2 Europe Single Cell Multiomics Market Size by Country (2017-2022)
7.3 Europe Single Cell Multiomics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Cell Multiomics Market Size (2017-2028)
8.2 Asia-Pacific Single Cell Multiomics Market Size by Country (2017-2022)
8.3 Asia-Pacific Single Cell Multiomics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Single Cell Multiomics Market Size (2017-2028)
9.2 Latin America Single Cell Multiomics Market Size by Country (2017-2022)
9.3 Latin America Single Cell Multiomics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Cell Multiomics Market Size (2017-2028)
10.2 Middle East & Africa Single Cell Multiomics Market Size by Country (2017-2022)
10.3 Middle East & Africa Single Cell Multiomics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Single Cell Multiomics Introduction
11.1.4 10x Genomics Revenue in Single Cell Multiomics Business (2017-2022)
11.1.5 10x Genomics Recent Development
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Detail
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Single Cell Multiomics Introduction
11.2.4 Becton, Dickinson and Company Revenue in Single Cell Multiomics Business (2017-2022)
11.2.5 Becton, Dickinson and Company Recent Development
11.3 Berkeley Lights
11.3.1 Berkeley Lights Company Detail
11.3.2 Berkeley Lights Business Overview
11.3.3 Berkeley Lights Single Cell Multiomics Introduction
11.3.4 Berkeley Lights Revenue in Single Cell Multiomics Business (2017-2022)
11.3.5 Berkeley Lights Recent Development
11.4 BGI Genomics
11.4.1 BGI Genomics Company Detail
11.4.2 BGI Genomics Business Overview
11.4.3 BGI Genomics Single Cell Multiomics Introduction
11.4.4 BGI Genomics Revenue in Single Cell Multiomics Business (2017-2022)
11.4.5 BGI Genomics Recent Development
11.5 Bio Rad Laboratories
11.5.1 Bio Rad Laboratories Company Detail
11.5.2 Bio Rad Laboratories Business Overview
11.5.3 Bio Rad Laboratories Single Cell Multiomics Introduction
11.5.4 Bio Rad Laboratories Revenue in Single Cell Multiomics Business (2017-2022)
11.5.5 Bio Rad Laboratories Recent Development
11.6 Danaher Corporation (Cytiva Life Sciences)
11.6.1 Danaher Corporation (Cytiva Life Sciences) Company Detail
11.6.2 Danaher Corporation (Cytiva Life Sciences) Business Overview
11.6.3 Danaher Corporation (Cytiva Life Sciences) Single Cell Multiomics Introduction
11.6.4 Danaher Corporation (Cytiva Life Sciences) Revenue in Single Cell Multiomics Business (2017-2022)
11.6.5 Danaher Corporation (Cytiva Life Sciences) Recent Development
11.7 Dolomite Bio
11.7.1 Dolomite Bio Company Detail
11.7.2 Dolomite Bio Business Overview
11.7.3 Dolomite Bio Single Cell Multiomics Introduction
11.7.4 Dolomite Bio Revenue in Single Cell Multiomics Business (2017-2022)
11.7.5 Dolomite Bio Recent Development
11.8 Epicypher
11.8.1 Epicypher Company Detail
11.8.2 Epicypher Business Overview
11.8.3 Epicypher Single Cell Multiomics Introduction
11.8.4 Epicypher Revenue in Single Cell Multiomics Business (2017-2022)
11.8.5 Epicypher Recent Development
11.9 Fluidigm Corporation
11.9.1 Fluidigm Corporation Company Detail
11.9.2 Fluidigm Corporation Business Overview
11.9.3 Fluidigm Corporation Single Cell Multiomics Introduction
11.9.4 Fluidigm Corporation Revenue in Single Cell Multiomics Business (2017-2022)
11.9.5 Fluidigm Corporation Recent Development
11.10 Illimina
11.10.1 Illimina Company Detail
11.10.2 Illimina Business Overview
11.10.3 Illimina Single Cell Multiomics Introduction
11.10.4 Illimina Revenue in Single Cell Multiomics Business (2017-2022)
11.10.5 Illimina Recent Development
11.11 Miltenyi Biotec B.V. & CO.
11.11.1 Miltenyi Biotec B.V. & CO. Company Detail
11.11.2 Miltenyi Biotec B.V. & CO. Business Overview
11.11.3 Miltenyi Biotec B.V. & CO. Single Cell Multiomics Introduction
11.11.4 Miltenyi Biotec B.V. & CO. Revenue in Single Cell Multiomics Business (2017-2022)
11.11.5 Miltenyi Biotec B.V. & CO. Recent Development
11.12 Mission Bio
11.12.1 Mission Bio Company Detail
11.12.2 Mission Bio Business Overview
11.12.3 Mission Bio Single Cell Multiomics Introduction
11.12.4 Mission Bio Revenue in Single Cell Multiomics Business (2017-2022)
11.12.5 Mission Bio Recent Development
11.13 Nanostring Technologies
11.13.1 Nanostring Technologies Company Detail
11.13.2 Nanostring Technologies Business Overview
11.13.3 Nanostring Technologies Single Cell Multiomics Introduction
11.13.4 Nanostring Technologies Revenue in Single Cell Multiomics Business (2017-2022)
11.13.5 Nanostring Technologies Recent Development
11.14 Olink Holding AB (Olink Proteomics)
11.14.1 Olink Holding AB (Olink Proteomics) Company Detail
11.14.2 Olink Holding AB (Olink Proteomics) Business Overview
11.14.3 Olink Holding AB (Olink Proteomics) Single Cell Multiomics Introduction
11.14.4 Olink Holding AB (Olink Proteomics) Revenue in Single Cell Multiomics Business (2017-2022)
11.14.5 Olink Holding AB (Olink Proteomics) Recent Development
11.15 Parse Bioscience
11.15.1 Parse Bioscience Company Detail
11.15.2 Parse Bioscience Business Overview
11.15.3 Parse Bioscience Single Cell Multiomics Introduction
11.15.4 Parse Bioscience Revenue in Single Cell Multiomics Business (2017-2022)
11.15.5 Parse Bioscience Recent Development
11.16 Qiagen N.V.
11.16.1 Qiagen N.V. Company Detail
11.16.2 Qiagen N.V. Business Overview
11.16.3 Qiagen N.V. Single Cell Multiomics Introduction
11.16.4 Qiagen N.V. Revenue in Single Cell Multiomics Business (2017-2022)
11.16.5 Qiagen N.V. Recent Development
11.17 Takara Holdings Inc. Takara Bio Group
11.17.1 Takara Holdings Inc. Takara Bio Group Company Detail
11.17.2 Takara Holdings Inc. Takara Bio Group Business Overview
11.17.3 Takara Holdings Inc. Takara Bio Group Single Cell Multiomics Introduction
11.17.4 Takara Holdings Inc. Takara Bio Group Revenue in Single Cell Multiomics Business (2017-2022)
11.17.5 Takara Holdings Inc. Takara Bio Group Recent Development
11.18 Thermo Fisher Scientific
11.18.1 Thermo Fisher Scientific Company Detail
11.18.2 Thermo Fisher Scientific Business Overview
11.18.3 Thermo Fisher Scientific Single Cell Multiomics Introduction
11.18.4 Thermo Fisher Scientific Revenue in Single Cell Multiomics Business (2017-2022)
11.18.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Single Cell Multiomics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Single cell genomics
Table 3. Key Players of Single cell proteomics
Table 4. Key Players of Single cell transcriptomics
Table 5. Key Players of Single cell metabolomics
Table 6. Global Single Cell Multiomics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Single Cell Multiomics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Single Cell Multiomics Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Single Cell Multiomics Market Share by Region (2017-2022)
Table 10. Global Single Cell Multiomics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Single Cell Multiomics Market Share by Region (2023-2028)
Table 12. Single Cell Multiomics Market Trends
Table 13. Single Cell Multiomics Market Drivers
Table 14. Single Cell Multiomics Market Challenges
Table 15. Single Cell Multiomics Market Restraints
Table 16. Global Single Cell Multiomics Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Single Cell Multiomics Market Share by Players (2017-2022)
Table 18. Global Top Single Cell Multiomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cell Multiomics as of 2021)
Table 19. Ranking of Global Top Single Cell Multiomics Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Single Cell Multiomics Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Single Cell Multiomics Product Solution and Service
Table 23. Date of Enter into Single Cell Multiomics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Single Cell Multiomics Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Single Cell Multiomics Revenue Market Share by Type (2017-2022)
Table 27. Global Single Cell Multiomics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Single Cell Multiomics Revenue Market Share by Type (2023-2028)
Table 29. Global Single Cell Multiomics Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Single Cell Multiomics Revenue Market Share by Application (2017-2022)
Table 31. Global Single Cell Multiomics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Single Cell Multiomics Revenue Market Share by Application (2023-2028)
Table 33. North America Single Cell Multiomics Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Single Cell Multiomics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Single Cell Multiomics Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Single Cell Multiomics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Single Cell Multiomics Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Single Cell Multiomics Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Single Cell Multiomics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Single Cell Multiomics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Single Cell Multiomics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Single Cell Multiomics Market Size by Country (2023-2028) & (US$ Million)
Table 43. 10x Genomics Company Detail
Table 44. 10x Genomics Business Overview
Table 45. 10x Genomics Single Cell Multiomics Product
Table 46. 10x Genomics Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 47. 10x Genomics Recent Development
Table 48. Becton, Dickinson and Company Company Detail
Table 49. Becton, Dickinson and Company Business Overview
Table 50. Becton, Dickinson and Company Single Cell Multiomics Product
Table 51. Becton, Dickinson and Company Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 52. Becton, Dickinson and Company Recent Development
Table 53. Berkeley Lights Company Detail
Table 54. Berkeley Lights Business Overview
Table 55. Berkeley Lights Single Cell Multiomics Product
Table 56. Berkeley Lights Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 57. Berkeley Lights Recent Development
Table 58. BGI Genomics Company Detail
Table 59. BGI Genomics Business Overview
Table 60. BGI Genomics Single Cell Multiomics Product
Table 61. BGI Genomics Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 62. BGI Genomics Recent Development
Table 63. Bio Rad Laboratories Company Detail
Table 64. Bio Rad Laboratories Business Overview
Table 65. Bio Rad Laboratories Single Cell Multiomics Product
Table 66. Bio Rad Laboratories Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 67. Bio Rad Laboratories Recent Development
Table 68. Danaher Corporation (Cytiva Life Sciences) Company Detail
Table 69. Danaher Corporation (Cytiva Life Sciences) Business Overview
Table 70. Danaher Corporation (Cytiva Life Sciences) Single Cell Multiomics Product
Table 71. Danaher Corporation (Cytiva Life Sciences) Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 72. Danaher Corporation (Cytiva Life Sciences) Recent Development
Table 73. Dolomite Bio Company Detail
Table 74. Dolomite Bio Business Overview
Table 75. Dolomite Bio Single Cell Multiomics Product
Table 76. Dolomite Bio Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 77. Dolomite Bio Recent Development
Table 78. Epicypher Company Detail
Table 79. Epicypher Business Overview
Table 80. Epicypher Single Cell Multiomics Product
Table 81. Epicypher Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 82. Epicypher Recent Development
Table 83. Fluidigm Corporation Company Detail
Table 84. Fluidigm Corporation Business Overview
Table 85. Fluidigm Corporation Single Cell Multiomics Product
Table 86. Fluidigm Corporation Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 87. Fluidigm Corporation Recent Development
Table 88. Illimina Company Detail
Table 89. Illimina Business Overview
Table 90. Illimina Single Cell Multiomics Product
Table 91. Illimina Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 92. Illimina Recent Development
Table 93. Miltenyi Biotec B.V. & CO. Company Detail
Table 94. Miltenyi Biotec B.V. & CO. Business Overview
Table 95. Miltenyi Biotec B.V. & CO. Single Cell MultiomicsProduct
Table 96. Miltenyi Biotec B.V. & CO. Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 97. Miltenyi Biotec B.V. & CO. Recent Development
Table 98. Mission Bio Company Detail
Table 99. Mission Bio Business Overview
Table 100. Mission Bio Single Cell MultiomicsProduct
Table 101. Mission Bio Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 102. Mission Bio Recent Development
Table 103. Nanostring Technologies Company Detail
Table 104. Nanostring Technologies Business Overview
Table 105. Nanostring Technologies Single Cell MultiomicsProduct
Table 106. Nanostring Technologies Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 107. Nanostring Technologies Recent Development
Table 108. Olink Holding AB (Olink Proteomics) Company Detail
Table 109. Olink Holding AB (Olink Proteomics) Business Overview
Table 110. Olink Holding AB (Olink Proteomics) Single Cell MultiomicsProduct
Table 111. Olink Holding AB (Olink Proteomics) Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 112. Olink Holding AB (Olink Proteomics) Recent Development
Table 113. Parse Bioscience Company Detail
Table 114. Parse Bioscience Business Overview
Table 115. Parse Bioscience Single Cell MultiomicsProduct
Table 116. Parse Bioscience Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 117. Parse Bioscience Recent Development
Table 118. Qiagen N.V. Company Detail
Table 119. Qiagen N.V. Business Overview
Table 120. Qiagen N.V. Single Cell MultiomicsProduct
Table 121. Qiagen N.V. Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 122. Qiagen N.V. Recent Development
Table 123. Takara Holdings Inc. Takara Bio Group Company Detail
Table 124. Takara Holdings Inc. Takara Bio Group Business Overview
Table 125. Takara Holdings Inc. Takara Bio Group Single Cell MultiomicsProduct
Table 126. Takara Holdings Inc. Takara Bio Group Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 127. Takara Holdings Inc. Takara Bio Group Recent Development
Table 128. Thermo Fisher Scientific Company Detail
Table 129. Thermo Fisher Scientific Business Overview
Table 130. Thermo Fisher Scientific Single Cell MultiomicsProduct
Table 131. Thermo Fisher Scientific Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 132. Thermo Fisher Scientific Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Single Cell Multiomics Market Share by Type: 2021 VS 2028
Figure 2. Single cell genomics Features
Figure 3. Single cell proteomics Features
Figure 4. Single cell transcriptomics Features
Figure 5. Single cell metabolomics Features
Figure 6. Global Single Cell Multiomics Market Share by Application in 2021 & 2028
Figure 7. Oncology Case Studies
Figure 8. Cell biology Case Studies
Figure 9. Neurology Case Studies
Figure 10. Immunology Case Studies
Figure 11. Stem cell research Case Studies
Figure 12. Single Cell Multiomics Report Years Considered
Figure 13. Global Single Cell Multiomics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Single Cell Multiomics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Single Cell Multiomics Market Share by Region: 2021 VS 2028
Figure 16. Global Single Cell Multiomics Market Share by Players in 2021
Figure 17. Global Top Single Cell Multiomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cell Multiomics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Single Cell Multiomics Revenue in 2021
Figure 19. North America Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Single Cell Multiomics Market Share by Country (2017-2028)
Figure 21. United States Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Single Cell Multiomics Market Share by Country (2017-2028)
Figure 25. Germany Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Single Cell Multiomics Market Share by Region (2017-2028)
Figure 33. China Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Single Cell Multiomics Market Share by Country (2017-2028)
Figure 41. Mexico Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Single Cell Multiomics Market Share by Country (2017-2028)
Figure 45. Turkey Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. 10x Genomics Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 48. Becton, Dickinson and Company Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 49. Berkeley Lights Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 50. BGI Genomics Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 51. Bio Rad Laboratories Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 52. Danaher Corporation (Cytiva Life Sciences) Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 53. Dolomite Bio Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 54. Epicypher Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 55. Fluidigm Corporation Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 56. Illimina Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 57. Miltenyi Biotec B.V. & CO. Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 58. Mission Bio Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 59. Nanostring Technologies Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 60. Olink Holding AB (Olink Proteomics) Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 61. Parse Bioscience Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 62. Qiagen N.V. Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 63. Takara Holdings Inc. Takara Bio Group Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
